US Stock MarketDetailed Quotes

REGN Regeneron Pharmaceuticals

Watchlist
  • 973.800
  • +5.800+0.60%
Close May 10 16:00 ET
  • 973.000
  • -0.800-0.08%
Post 18:27 ET
107.30BMarket Cap28.75P/E (TTM)

Regeneron Pharmaceuticals Key Stats

Regeneron Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 2, 2024

Revenue(YoY)

3.15B

-0.54%
EPS(YoY)

6.27

-12.55%

Strong Buy

May 11, 2024

Regeneron Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 19 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 3.561B--
--2024/Q2-- / 3.386B--
May 2, 20242024/Q13.145B / 3.221B--
Feb 2, 20242023/Q43.434B / 3.287B--
Nov 2, 20232023/Q33.363B / 3.222B--
Aug 3, 20232023/Q23.158B / 3.025B--
May 4, 20232023/Q13.162B / 2.998B--
--2022/Q43.414B / 3.113B--
Nov 3, 20222022/Q32.936B / 2.870B--
Aug 3, 20222022/Q22.857B / 2.797B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 3.561B--
--2024/Q2-- / 3.386B--
May 2, 20242024/Q13.145B / 3.221B--
Feb 2, 20242023/Q43.434B / 3.287B--
Nov 2, 20232023/Q33.363B / 3.222B--
Aug 3, 20232023/Q23.158B / 3.025B--
May 4, 20232023/Q13.162B / 2.998B--
--2022/Q43.414B / 3.113B--
Nov 3, 20222022/Q32.936B / 2.870B--
Aug 3, 20222022/Q22.857B / 2.797B--

Unlock Free Earnings Estimates

Regeneron Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: May 11, 2024

Strong Buy

  • Buy

    80.95%
  • Hold

    14.29%
  • Sell

    4.76%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg